{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:30:25Z","timestamp":1791311425955,"version":"4.3.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T00:00:00Z","timestamp":1341532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Transplantation of isolated islet of Langerhans cells has great potential as a cure for type 1 diabetes but continuous immune suppressive therapy often causes considerable side effects. Tapering of immunosuppression in successfully transplanted patients would lower patients' health risk. To identify immune biomarkers that may prove informative in monitoring tapering, we studied the effect of tapering on islet auto- and alloimmune reactivity in a pilot study in five transplant recipients in vitro. Cytokine responses to the graft were measured using Luminex technology. Avidity of alloreactive cytotoxic T Lymphocytes (CTL) was determined by CD8 blockade. The influence of immunosuppression was mimicked by in vitro replenishment of tacrolimus and MPA, the active metabolite of mycophenolate mofetil. Tapering of tacrolimus was generally followed by decreased C-peptide production. T-cell autoreactivity increased in four out of five patients during tapering. Overall alloreactive CTL precursor frequencies did not change, but their avidity to donor mismatches increased significantly after tapering (P\u2003=\u20030\u00b7035). In vitro addition of tacrolimus but not MPA strongly inhibited CTL alloreactivity during tapering and led to a significant shift to anti-inflammatory graft-specific cytokine production. Tapering of immunosuppression is characterized by diverse immune profiles that appear to relate inversely to plasma C-peptide levels. Highly avid allospecific CTLs that are known to associate with rejection increased during tapering, but could be countered by restoring immune suppression in vitro. Immune monitoring studies may help guiding tapering of immunosuppression after islet cell transplantation, even though we do not have formal prove yet that the observed changes reflect direct effects of immune suppression on immunity.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2012.04605.x","type":"journal-article","created":{"date-parts":[[2012,7,6]],"date-time":"2012-07-06T13:54:33Z","timestamp":1341582873000},"page":"190-198","source":"Crossref","is-referenced-by-count":24,"title":["Immune responses against islet allografts during tapering of immunosuppression \u2013 a pilot study in 5 subjects"],"prefix":"10.1093","volume":"169","author":[{"given":"V A L","family":"Huurman","sequence":"first","affiliation":[{"name":"Department of Immunohaematology and Blood Transfusion"},{"name":"Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C R","family":"van der Torren","sequence":"additional","affiliation":[{"name":"Department of Immunohaematology and Blood Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Gillard","sequence":"additional","affiliation":[{"name":"Endocrinology, Universitair Ziekenhuis Gasthuisberg, Catholic University of Leuven, Leuven"},{"name":"Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hilbrands","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E P M W","family":"van der Meer-Prins","sequence":"additional","affiliation":[{"name":"Department of Immunohaematology and Blood Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Duinkerken","sequence":"additional","affiliation":[{"name":"Department of Immunohaematology and Blood Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F K","family":"Gorus","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F H J","family":"Claas","sequence":"additional","affiliation":[{"name":"Department of Immunohaematology and Blood Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Keymeulen","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D L","family":"Roelen","sequence":"additional","affiliation":[{"name":"Department of Immunohaematology and Blood Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D G","family":"Pipeleers","sequence":"additional","affiliation":[{"name":"Diabetes Research Center, Brussels Free University-VUB, Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B O","family":"Roep","sequence":"additional","affiliation":[{"name":"Department of Immunohaematology and Blood Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,7,6]]},"reference":[{"key":"2021122708375686800_b1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"2021122708375686800_b2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nri1332","article-title":"Clinical islet transplantation: advances and immunological challenges","volume":"4","author":"Ricordi","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"2021122708375686800_b3","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122708375686800_b4","doi-asserted-by":"crossref","first-page":"17444","DOI":"10.1073\/pnas.0608141103","article-title":"Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft","volume":"103","author":"Keymeulen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021122708375686800_b5","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"key":"2021122708375686800_b6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00007890-199559040-00006","article-title":"Primary kidney tumors before and after renal transplantation","volume":"59","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"2021122708375686800_b7","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ-transplant recipients","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122708375686800_b8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.critrevonc.2005.03.015","article-title":"Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation","volume":"56","author":"Taylor","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"2021122708375686800_b9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol Rev"},{"key":"2021122708375686800_b10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00007890-199109000-00026","article-title":"In vivo effect of FK506 on human pancreatic islets","volume":"52","author":"Ricordi","year":"1991","journal-title":"Transplantation"},{"key":"2021122708375686800_b11","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2337\/db06-0173","article-title":"Sirolimus is associated with reduced islet engraftment and impaired beta-cell function","volume":"55","author":"Zhang","year":"2006","journal-title":"Diabetes"},{"key":"2021122708375686800_b12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3727\/096368909X471198","article-title":"Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets","volume":"18","author":"Johnson","year":"2009","journal-title":"Cell Transplant"},{"key":"2021122708375686800_b13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1600-6143.2006.01280.x","article-title":"Clinical operational tolerance after kidney transplantation","volume":"6","author":"Roussey-Kesler","year":"2006","journal-title":"Am J Transplant"},{"key":"2021122708375686800_b14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2009.03.006","article-title":"Operational tolerance after liver transplantation","volume":"50","author":"Orlando","year":"2009","journal-title":"J Hepatol"},{"key":"2021122708375686800_b15","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/SLA.0b013e3181f3efb0","article-title":"Clinical operational tolerance after renal transplantation: current status and future challenges","volume":"252","author":"Orlando","year":"2010","journal-title":"Ann Surg"},{"key":"2021122708375686800_b16","doi-asserted-by":"crossref","first-page":"e2435","DOI":"10.1371\/journal.pone.0002435","article-title":"Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation","volume":"3","author":"Huurman","year":"2008","journal-title":"PLoS ONE"},{"key":"2021122708375686800_b17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1600-6143.2008.02479.x","article-title":"Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation","volume":"9","author":"Huurman","year":"2009","journal-title":"Am J Transplant"},{"key":"2021122708375686800_b18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2249.2008.03812.x","article-title":"Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation","volume":"156","author":"Roelen","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"2021122708375686800_b19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00007890-199204000-00035","article-title":"Evidence that antibody formation against a certain HLA alloantigen is associated not with a quantitative but with a qualitative change in the cytotoxic T cells recognizing the same antigen","volume":"53","author":"Roelen","year":"1992","journal-title":"Transplantation"},{"key":"2021122708375686800_b20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2337\/diabetes.48.3.484","article-title":"Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients","volume":"48","author":"Roep","year":"1999","journal-title":"Diabetes"},{"key":"2021122708375686800_b21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/diacare.23.6.838","article-title":"High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry","volume":"23","author":"Decochez","year":"2000","journal-title":"Diabetes Care"},{"key":"2021122708375686800_b22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0198-8859(92)90015-F","article-title":"Determination of cytotoxic T-lymphocyte precursor frequencies using europium labeling as a nonradioactive alternative to labeling with chromium-51","volume":"35","author":"Bouma","year":"1992","journal-title":"Hum Immunol"},{"key":"2021122708375686800_b23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0020-7101(88)90020-7","article-title":"Computer aided design and evaluation of limiting and serial dilution experiments","volume":"23","author":"Strijbosch","year":"1988","journal-title":"Int J Biomed Comput"},{"key":"2021122708375686800_b24","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00007890-199307000-00035","article-title":"Differential inhibition of primed alloreactive CTLs in vitro by clinically used concentrations of cyclosporine and FK506","volume":"56","author":"Roelen","year":"1993","journal-title":"Transplantation"},{"key":"2021122708375686800_b25","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0022-3565(24)35215-2","article-title":"Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics","volume":"291","author":"Gummert","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"2021122708375686800_b26","first-page":"1806","article-title":"Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells","volume":"118","author":"Monti","year":"2008","journal-title":"J Clin Invest"},{"key":"2021122708375686800_b27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5414\/CPP43379","article-title":"Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients","volume":"43","author":"Merkel","year":"2005","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2021122708375686800_b28","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.2337\/diabetes.53.12.3107","article-title":"Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome","volume":"53","author":"Street","year":"2004","journal-title":"Diabetes"},{"key":"2021122708375686800_b29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3727\/096368909X470874","article-title":"2007 update on allogeneic islet transplantation from the Collaborative Islet Transplant Registry (CITR)","volume":"18","author":"The CITR Research Group","year":"2009","journal-title":"Cell Transplant"},{"key":"2021122708375686800_b30","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.2337\/diab.45.12.1814","article-title":"Long-term metabolic control by rat islet grafts depends on the composition of the implant","volume":"45","author":"Keymeulen","year":"1996","journal-title":"Diabetes"},{"key":"2021122708375686800_b31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1399-0012.2007.00754.x","article-title":"After discontinuation of calcineurin inhibitors, tapering of mycophenolate mofetil further impairs donor-directed cytotoxicity","volume":"22","author":"van Besouw","year":"2008","journal-title":"Clin Transplant"},{"key":"2021122708375686800_b32","first-page":"3390","article-title":"CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope","volume":"118","author":"Skowera","year":"2008","journal-title":"J Clin Invest"},{"key":"2021122708375686800_b33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1097\/00007890-199311000-00033","article-title":"The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection","volume":"56","author":"Ouwehand","year":"1993","journal-title":"Transplantation"},{"key":"2021122708375686800_b34","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/00007890-199504150-00021","article-title":"The presence of activated donor HLA class I-reactive T lymphocytes is associated with rejection of corneal grafts","volume":"59","author":"Roelen","year":"1995","journal-title":"Transplantation"},{"key":"2021122708375686800_b35","first-page":"413","article-title":"HLA sensitization in islet transplantation","volume":"15","author":"Rickels","year":"2006","journal-title":"Clin Transpl"},{"key":"2021122708375686800_b36","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1600-6143.2007.01923.x","article-title":"High risk of sensitization after failed islet transplantation","volume":"7","author":"Campbell","year":"2007","journal-title":"Am J Transplant"},{"key":"2021122708375686800_b37","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2337\/db09-0498","article-title":"Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells","volume":"59","author":"Vendrame","year":"2010","journal-title":"Diabetes"},{"key":"2021122708375686800_b38","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2337\/db09-0160","article-title":"Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients","volume":"58","author":"Hilbrands","year":"2009","journal-title":"Diabetes"},{"key":"2021122708375686800_b39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.2042-7158.1994.tb03752.x","article-title":"Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes","volume":"46","author":"Nagase","year":"1994","journal-title":"J Pharm Pharmacol"},{"key":"2021122708375686800_b40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1053-2498(98)00002-3","article-title":"Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring","volume":"18","author":"Meiser","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"2021122708375686800_b41","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/1098-2752(2000)20:8<420::AID-MICR13>3.0.CO;2-O","article-title":"Immunosuppressive agents in transplantation: mechanisms of action and current anti-rejection strategies","volume":"20","author":"Gorantla","year":"2000","journal-title":"Microsurgery"},{"key":"2021122708375686800_b42","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"2021122708375686800_b43","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.4049\/jimmunol.1000560","article-title":"Critical role for TNF in the induction of human antigen-specific regulatory T cells by tolerogenic dendritic cells","volume":"185","author":"Kleijwegt","year":"2010","journal-title":"J Immunol"},{"key":"2021122708375686800_b44","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.4049\/jimmunol.1003868","article-title":"Natural but not inducible regulatory T cells require TNF-{alpha} signaling for in vivo function","volume":"186","author":"Housley","year":"2011","journal-title":"J Immunol"},{"key":"2021122708375686800_b45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2249.2010.04183.x","article-title":"The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins","volume":"161","author":"Sewgobind","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021122708375686800_b46","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.4049\/jimmunol.178.9.5419","article-title":"Clinical transplantation tolerance: many rivers to cross","volume":"178","author":"Salama","year":"2007","journal-title":"J Immunol"},{"key":"2021122708375686800_b47","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/db09-1486","article-title":"Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers","volume":"59","author":"Velthuis","year":"2010","journal-title":"Diabetes"},{"key":"2021122708375686800_b48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.0105-2896.2006.00406.x","article-title":"Infectious tolerance and the long-term acceptance of transplanted tissue","volume":"212","author":"Waldmann","year":"2006","journal-title":"Immunol Rev"},{"key":"2021122708375686800_b49","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/TP.0b013e3181bbee98","article-title":"The human \u2018Treg MLR\u2019: immune monitoring for FOXP3+ T regulatory cell generation","volume":"88","author":"Levitsky","year":"2009","journal-title":"Transplantation"},{"key":"2021122708375686800_b50","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2337\/db09-0503","article-title":"Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression","volume":"59","author":"Tree","year":"2010","journal-title":"Diabetes"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2012.04605.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/169\/2\/190\/41907665\/j.1365-2249.2012.04605.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/169\/2\/190\/41907665\/j.1365-2249.2012.04605.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T12:11:30Z","timestamp":1743682290000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/169\/2\/190\/6438576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,6]]},"references-count":50,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,7,6]]},"published-print":{"date-parts":[[2012,7,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04605.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,8]]},"published":{"date-parts":[[2012,7,6]]}}}